 |
|
 |
Genetics: Familial Hypercholesterolemia
Provided by: Harvard Medical School
Acknowledgement: This course is supported by educational grants from Celera and the Applera Charitable Foundation.
The differential diagnosis of early coronary artery disease contains a number of genetic and environmental eitiologies. This course will review one important genetic condition which needs to be considered and ruled out when evaluati... |
|
Management of Hyperlipidemia
Provided by: Harvard Medical School
Abnormalities in lipid metabolism contribute to increased risk for developing coronary heart disease and other forms of vascular disease. This course will review current guidelines for patients with a variety of lipid disorders.... |
 |
Acute Myocardial Infarction: Reducing the Risk of Missed Diagnosis
Provided by: Medical Interactive Community
Acute Myocardial Infarction (AMI) often presents clinically in an evolving and confounding manner, creating a risk-laden situation for both patient and physician. Missed or delayed diagnosis is the most common medical misadventure for primary care and emergency physicians. This Internet self-paced activity presents malpractice claims data and rese... |
 |
Lipid Management
Provided by: Ohio Northern University
Objectives:
1. Review the pathophysiology of cholesterol homestasis.
2. Indentify tradional cardiac risk factors.
3. Determine appropriate lipid management goals based on current guidelines.
4. Recommend appropriate therapy for lipid ;management based on current guidelines.
5. Recognize the difference between atherosclerotic indicator... |
|
Professional Liability Risks for Family and General Practice
Provided by: Medical Interactive Community
Primary care physicians are in short supply, posing the risk of patient overload and increased medical error. Malpractice claims for Family and General Practitioners are on the rise. This Internet presentation reviews the most common medical misadventures for Family and General Practice (missed or delayed diagnosis of myocardial infarction, breast ... |
 |
How Thick is Too Thick for your Arteries? Ezetimibe vs Niacin for Cardiovascular Risk Reduction?
Provided by: Pharmacy Society of Wisconsin
* Compare second-line lipid lowering agents for special patient populations
* Assess carotid artery media thickness as a clinical endpoint
* Evaluate the primary literature of ezetimibe versus niacin as a guide for therapy management of cardiovascular risk reduction... |
 |
Management of Insulin Dependent Diabetes
Provided by: The Ohio State University Medical Center
Description
According to the National Institutes of Health, with Type 1 diabetes, the pancreas does not make insulin. Over time, high blood glucose can lead to serious problems with the heart, eyes, kidneys, nerves, and gums and teeth.
Objectives
Upon completion of this educational activity, the participant will be able to: 1.) Describe how th... |
|
Management of Myocardial Infarction
Provided by: The Ohio State University Medical Center
Description
According to National Institutes of Health, most heart attacks are caused by a blood clot that blocks one of the coronary arteries. The coronary arteries bring blood and oxygen to the heart. If the blood flow is blocked, the heart starves for oxygen and heart cells die.
Objectives
Upon completion of this educational acitivity the p... |
 |
Clinical Utility of Non-HDL-Cholesterol in the Management of Dyslipidemia
Provided by: Johns Hopkins School of Medicine
The Johns Hopkins University School of Medicine Self-Assessment Program (JHU-SAPâ„¢) is a clinical problem-solving, evidence-based continuing education program of active engagement. It is designed to objectively assess and strengthen your knowledge of non-HDL-cholesterol and provide you with a better understanding of its use in managing patients wi... |
 |
Cardiovascular Benefits of Aggressive Cholesterol-Lowering Therapy
Provided by: Impact Education, LLC
Purpose Statement
A 10-year follow up of the original Lipid Treatment Assessment Project (L-TAP) survey was recently published. Overall, 73% of patients reached their LDL-C goal; in high-risk patients, the rate was 67%. Despite this improvement, in high-risk patients (i.e., CHD plus ≥2 major risk factors such as diabetes, hypertension, and smoki... |
 |
Management of Dyslipidemias: NCEP ATP III 2011 Updates and Looking Beyond LDL
Provided by: CRM Healthcare
Management of cardiovascular disease is a rapidly changing area of clinical practice, with emerging research and practice altering widely accepted tenets. While the importance of treating dyslipidemias based on cardiovascular risk factors is highlighted by the NCEP ATP III clinical practice guidelines, recent clinical trials reveal the focus on dy... |
 |
Founder Effect in Familial Hypercholesterolemia (FH): A Focus on Early Detection and Treatment to Prevent Premature CHD in FH
Provided by: Primary Issues
Program Overview
Familial hypercholesterolemia (FH) is a common autosomal dominant genetic disorder associated with premature cardiovascular disease. The prevalence of heterozygous FH is as high as 1 in 67 for some founder populations such as Ashkenazi Jewish, French Canadians, or Lebanese populations. Primary care clinicians play an important ro... |
|
Best Practices in Primary Care: Dyslipidemia and the Chronic Kidney Disease Patient
Provided by: Primary Issues
Program Overview
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality among people with chronic kidney disease (CKD). While the link between CVD and CKD is apparent, primary care providers are not effectively screening and treating patients with renal disease who are at enhanced risk for cardiovascular disease and events.
... |
|
|
Virtual Exhibits / Booths
